PAR-21-089: Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2021.
National Institutes of Health offered grants to colleges and universities. Applications closed on January 7, 2024.
From the official notice on Grants.gov, last changed December 13, 2023. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeCooperative Agreement
About this NIH notice
- Activity codeU42
- Clinical trialsNot allowed
- Funded byOD
- Median yearly award$510,503
- Typical project length23.5 years
Projects funded under PAR-21-089 were run by NIH Office of the Director (OD, 7 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read PAR-21-089 in the NIH Guide.
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| PAR-24-078 | January 9, 2024 | Closed January 25, 2024 | Closed |
Key dates
| Posted | January 8, 2021 |
|---|---|
| Deadline | January 7, 2024 |
| Archived by Grants.gov | February 6, 2024 |
Who can apply
This opportunity was open to colleges and universities.
- Public and State controlled institutions of higher education
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See funding announcement for eligibility criteria
Is this a realistic fit?
- Most of the program's money (80% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The purpose of this Funding Opportunity Announcement is to provide continuing support for specific pathogen-free (SPF) macaque colonies previously funded under the auspices of PAR-18-669 and PAR-14-066. Breeding colonies are essential to sustain appropriate macaques for research related to Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS). Pedigree SPF macaques are free of certain viruses, which may confound the results of HIV/AIDS-related investigations or present a risk to the personnel who care for the animals. The SPF macaques are genetically characterized for major histocompatibility complex (MHC) class I types, because MHC class I genotypes have large effects on macaque immune responses to Simian Immunodeficiency Virus (SIV, which can induce AIDS in nonhuman primates (NHP)) and on human immune responses to HIV.
Funded under PAR-21-089 so far
NIH funded 7 projects under PAR-21-089 in fiscal 2022 to 2026, at 7 institutions. The median yearly award was $510,503.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Production of Pedigreed SPF Rhesus Macaques | University of California at Davis | 2026 | $1.2 million |
| MAINTENANCE OF THE CLOSED CPRC SPF COLONY | University of Puerto Rico Med Sciences | 2026 | $3.8 million |
| Establishment of a SPF Rhesus Macaque Colony | Texas Biomedical Research Institute | 2026 | $2.4 million |
| WaNPRC Macaca nemestrina SPF Breeding Colony | University of Washington | 2026 | $2.1 million |
| Viral Testing Core | Oregon Health & Science University | 2026 | $120,375 |
| Continued support for an SPF Macaca nemestrina breeding colony to provide animals to NIH funded HIV research projects | Johns Hopkins University | 2025 | $1.0 million |
| MHC Genetic Typing Core-Maintenance of the SPF Breeding Colonies at Yerkes National Primate Research Center | Emory University | 2025 | $510,503 |
Who has won Research Infrastructure Programs grants before
From fiscal 2021 to 2025, Research Infrastructure Programs (93.351) awarded $1.4 billion across 1,102 grant awards, an average of $1.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| University of California, Davis | California | 27 | $102 million |
| Oregon Health & Science University | Oregon | 18 | $92.1 million |
| University of Washington | Washington | 7 | $79.5 million |
| Emory University | Georgia | 14 | $78.3 million |
| The Administrators of Tulane Educational Fund | Louisiana | 10 | $68.0 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is PAR-21-089 still open?
No. It closed on January 7, 2024.
Who can apply for Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed)?
National Institutes of Health accepted applications from colleges and universities. The notice adds further conditions, so read its eligibility section.
What is the deadline for Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed)?
Closed January 7, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has been funded under PAR-21-089?
NIH RePORTER lists 7 projects funded under PAR-21-089 in fiscal 2022 to 2026, at 7 institutions. The most were at University of California at Davis, University of Puerto Rico Med Sciences, Texas Biomedical Research Institute.
Who has won Research Infrastructure Programs grants before?
The largest recipients over five fiscal years were University of California, Davis, Oregon Health & Science University, University of Washington. The program made 1,102 awards worth $1.4 billion in that time.
Similar open grants
- Research Resource for a National Swine Resource and Research Center (U42 Clinical Trial Not Allowed)
- Integrated Specific Pathogen Free Research Models and Human New Approach Methodologies to Advance HIV/AIDS Research (U42 Clinical Trial Not Allowed)
- Testing Centers for Evaluation of Somatic Cell Genome Editing Approaches for Translational Applications (U42 Clinical Trial Not Allowed)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)